A coalition,
not a brand.
Medivive isn't a manufacturer. We're the platform that brought together drug developers, a cGMP facility, a licensed pharmacy, and a telemedicine layer — so a pharmaceutical-grade NAD+ pen could reach you at home.
Demand has outpaced quality.
NAD+ is one of the fastest-growing therapeutics in clinical practice. The market for it is also flooded — with low-quality compounded product, unverified suppliers, and patients self-injecting formulations that haven't been tested for sterility or potency.
Medivive was built to fix that. We assembled specialists — each a recognized leader in their field — to deliver a high-quality NAD+ pen that is safe, consistent, and shippable to your door. The result is a single product, made by four organizations working in coordination, that anyone with a US address and a clean medical intake can access.
Four organizations, one product.
Medivive's role was to find the right partner for each part of the value chain and unify them into one workflow. No one builds a pharmaceutical-grade pen alone.
SpectrumX
UK-based developer behind the original NAD+ formulation. Holder of a Medical Specials license — a rare UK regulatory designation requiring rigorous manufacturing and testing standards.
VeV Scientific
FDA-registered cGMP 503B outsourcing facility in San Diego. Received the formulation from SpectrumX through a formal technology transfer and manufactures to the same standard.
Chemistry Rx
Licensed 503A pharmacy with PCAB accreditation and LegitScript certification. Dispenses every prescription cold-chain, direct to patients across 41 states.
SSRP Institute
Founded by Dr. William Seeds, MD — a leading clinical education organization for cellular medicine and peptide therapeutics. Medivive is a Trusted Partner of the Institute.
The SpectrumX drug development program.
SpectrumX, based in the United Kingdom, invested in a complete drug development program to create an NAD+ formulation with exceptional stability, potency, and purity. The program produced a prefilled subcutaneous injector pen delivering 1,000 mg of NAD+ as a 30-day supply, with adjustable dosing (1 unit = 3.33 mg).
SpectrumX holds a Medical Specials license — a UK regulatory designation requiring rigorous manufacturing, testing, and documentation standards.
That is the standard the Medivive NAD+ pen was developed to. When the formulation was transferred to VeV Scientific in San Diego, it carried that quality bar with it.
Medivive: the layer that ties it together.
The coalition is the foundation. Medivive is the technology layer that connects them. We built the patient-facing intake, the physician review workflow, the prescription routing to Chemistry Rx, the cold-chain shipping, and refill management — so that what looks like a single purchase on your end is actually four organizations working in concert.
This is what makes the Medivive NAD+ pen different from any other compounded NAD+ product: drug-development origin, cGMP manufacturing, licensed pharmacy dispensing, clinical education backing, and one telemedicine platform that makes all of it work as a single product.
How we stay compliant.
The Medivive supply chain operates within the DQSA and Section 503B framework. The arrangement supports compliant distribution from a 503B outsourcing facility to a state-licensed 503A pharmacy for patient-specific dispensing. A formal legal opinion letter from outside counsel is available to providers and serious prospective subscribers upon request.
Every prescription is reviewed by a US-licensed physician. Every batch is tested for potency, sterility, and endotoxins. Every shipment is cold-chain tracked. The Medivive brand is the front door — but the rigor lives in the coalition behind it.
You've read the story.
Take the intake.
Three minutes. Reviewed by a licensed physician. Cold-chain shipped to your door if approved. No charge if not.
Start Your Consult Meet the partners